Literature DB >> 12063262

Nuclear translocation of insulin receptor substrate-1 by the simian virus 40 T antigen and the activated type 1 insulin-like growth factor receptor.

Marco Prisco1, Francesca Santini, Raffaele Baffa, Mingli Liu, Robert Drakas, An Wu, Renato Baserga.   

Abstract

32D cells are a murine hemopoietic cell line that undergoes apoptosis upon withdrawal of interleukin-3 (IL-3) from the medium. 32D cells have low levels of the type 1 insulin-like growth factor (IGF-I) receptor and do not express insulin receptor substrate-1 (IRS-1) or IRS-2. Ectopic expression of IRS-1 delays apoptosis but cannot rescue 32D cells from IL-3 dependence. In 32D/IRS-1 cells, IRS-1 is detectable, as expected, in the cytosol/membrane compartment. The SV40 large T antigen is a nuclear protein that, by itself, also fails to protect 32D cells from apoptosis. Co-expression of IRS-1 with the SV40 T antigen in 32D cells results in nuclear translocation of IRS-1 and survival after IL-3 withdrawal. Expression of a human IGF-I receptor in 32D/IRS-1 cells also results in nuclear translocation of IRS-1 and IL-3 independence. The phosphotyrosine-binding domain, but not the pleckstrin domain, is necessary for IRS-1 nuclear translocation. Nuclear translocation of IRS-1 was confirmed in mouse embryo fibroblasts. These results suggest possible new roles for nuclear IRS-1 in IGF-I-mediated growth and anti-apoptotic signaling.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12063262     DOI: 10.1074/jbc.M204658200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Nuclear IGF1R is a transcriptional co-activator of LEF1/TCF.

Authors:  Dudi Warsito; Sylvia Sjöström; Sandra Andersson; Olle Larsson; Bita Sehat
Journal:  EMBO Rep       Date:  2012-03-01       Impact factor: 8.807

2.  Expression of nuclear insulin receptor substrate 1 in breast cancer.

Authors:  Diego Sisci; Catia Morelli; Cecilia Garofalo; Francesco Romeo; Lucio Morabito; Filomena Casaburi; Emilia Middea; Sandra Cascio; Elvira Brunelli; Sebastiano Andò; Eva Surmacz
Journal:  J Clin Pathol       Date:  2006-08-01       Impact factor: 3.411

Review 3.  Nuclear IRS-1 and cancer.

Authors:  Krzysztof Reiss; Luis Del Valle; Adam Lassak; Joanna Trojanek
Journal:  J Cell Physiol       Date:  2012-08       Impact factor: 6.384

4.  Membrane localization of insulin receptor substrate-2 (IRS-2) is associated with decreased overall survival in breast cancer.

Authors:  Jennifer L Clark; Karen Dresser; Chung-Cheng Hsieh; Michael Sabel; Celina G Kleer; Ashraf Khan; Leslie M Shaw
Journal:  Breast Cancer Res Treat       Date:  2011-01-22       Impact factor: 4.872

5.  Insulin receptor substrate-4 is overexpressed in colorectal cancer and promotes retinoblastoma-cyclin-dependent kinase activation.

Authors:  Patricia Sanmartín-Salinas; María Del Val Toledo Lobo; Fernando Noguerales-Fraguas; Miguel Toro Londoño; Antonio Jiménez-Ruiz; Luis Gonzalez Guijarro
Journal:  J Gastroenterol       Date:  2018-01-20       Impact factor: 7.527

6.  Cancer cell-derived clusterin modulates the phosphatidylinositol 3'-kinase-Akt pathway through attenuation of insulin-like growth factor 1 during serum deprivation.

Authors:  Hakryul Jo; Yonghui Jia; Kulandayan K Subramanian; Hidenori Hattori; Hongbo R Luo
Journal:  Mol Cell Biol       Date:  2008-05-05       Impact factor: 4.272

7.  IRS1 regulation by Wnt/beta-catenin signaling and varied contribution of IRS1 to the neoplastic phenotype.

Authors:  Guido T Bommer; Ying Feng; Ayaka Iura; Thomas J Giordano; Rork Kuick; Hüseyin Kadikoy; Deanna Sikorski; Rong Wu; Kathleen R Cho; Eric R Fearon
Journal:  J Biol Chem       Date:  2009-10-20       Impact factor: 5.157

Review 8.  Insulin receptor substrates (IRSs) and breast tumorigenesis.

Authors:  Bonita Tak-Yee Chan; Adrian V Lee
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-22       Impact factor: 2.673

9.  Molecular and Structural Traits of Insulin Receptor Substrate 1/LC3 Nuclear Structures and Their Role in Autophagy Control and Tumor Cell Survival.

Authors:  Adam Lassak; Mathew Dean; Dorota Wyczechowska; Anna Wilk; Luis Marrero; Jimena Trillo-Tinoco; A Hamid Boulares; Jann N Sarkaria; Luis Del Valle; Francesca Peruzzi; Augusto Ochoa; Krzysztof Reiss
Journal:  Mol Cell Biol       Date:  2018-04-30       Impact factor: 4.272

10.  Expression and function of the insulin receptor substrate proteins in cancer.

Authors:  Katerina Mardilovich; Shannon L Pankratz; Leslie M Shaw
Journal:  Cell Commun Signal       Date:  2009-06-17       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.